Study Designs and Statistical Analyses for Biomarker Research

被引：52
|
作者：
Gosho, Masahiko [1 ]
Nagashima, Kengo [1 ,2 ]
Sato, Yasunori [3 ]
机构：
[1] Tokyo Univ Sci, Grad Sch Engn, Shinjuku Ku, Tokyo 1628601, Japan
[2] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan
[3] Chiba Univ Med, Clin Res Ctr, Chuo Ku, Chiba 2608677, Japan
来源：
SENSORS | 2012年 / 12卷 / 07期
基金：
日本学术振兴会;
关键词：
biomarker adaptive design; confounding; multiplicity; predictive factor; statistical test; CLINICAL-TRIAL DESIGNS; FALSE DISCOVERY RATE; SURROGATE ENDPOINTS; GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; VALIDATION; POLYMORPHISMS; CHEMOTHERAPY; PROGNOSIS;
D O I：
10.3390/s120708966
中图分类号：
O65 [分析化学];
学科分类号：
070302 ; 081704 ;
摘要：
Biomarkers are becoming increasingly important for streamlining drug discovery and development. In addition, biomarkers are widely expected to be used as a tool for disease diagnosis, personalized medication, and surrogate endpoints in clinical research. In this paper, we highlight several important aspects related to study design and statistical analysis for clinical research incorporating biomarkers. We describe the typical and current study designs for exploring, detecting, and utilizing biomarkers. Furthermore, we introduce statistical issues such as confounding and multiplicity for statistical tests in biomarker research.
引用
收藏
页码：8966 / 8986
页数：21
相关论文
共 50 条
  • [1] Biomarker research with prospective study designs for the early detection of cancer
    Pesch, B.
    Breuning, T.
    Johnen, G.
    Casjens, S.
    Bonberg, N.
    Taeger, D.
    Mueller, A.
    Weber, D. G.
    Behrens, T.
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2014, 1844 (05): : 874 - 883
  • [2] Biomarker adaptive designs in clinical trials
    Chen, James J.
    Lu, Tzu-Pin
    Chen, Dung-Tsa
    Wang, Sue-Jane
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (03) : 279 - 292
  • [3] Evaluation of Excess Statistical Significance in Meta-analyses of 98 Biomarker Associations with Cancer Risk
    Tsilidis, Konstantinos K.
    Papatheodorou, Stefania I.
    Evangelou, Evangelos
    Ioannidis, John P. A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (24): : 1867 - 1878
  • [4] Statistical consideration for clinical biomarker research in bladder cancer
    Shariat, Shahrokh F.
    Lotan, Yair
    Vickers, Andrew
    Karakiewicz, Pierre I.
    Schmitz-Draeger, Bernd J.
    Goebell, Peter J.
    Malats, Nuria
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (04) : 389 - 400
  • [5] Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research
    Lai, Tze Leung
    Liao, Olivia Yueh-Wen
    Kim, Dong Woo
    CONTEMPORARY CLINICAL TRIALS, 2013, 36 (02) : 651 - 663
  • [6] Study designs in thoracic surgery research
    Viti, Andrea
    Terzi, Alberto
    Bertolaccini, Luca
    JOURNAL OF THORACIC DISEASE, 2016, 8 (09) : E932 - E934
  • [7] The efficiency of clinical trial designs for predictive biomarker validation
    Young, K. Y.
    Laird, A.
    Zhou, X. H.
    CLINICAL TRIALS, 2010, 7 (05) : 557 - 566
  • [8] Trial designs for biomarker assessment
    Billingham, Lucinda
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S281 - S281
  • [9] Statistical evaluation of a biomarker
    Ray, P.
    Le Manach, Y.
    Riou, B.
    Houle, T. T.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2011, 1 (05): : 355 - 372
  • [10] Optimizing Aggregated N-Of-1 Trial Designs for Predictive Biomarker Validation: Statistical Methods and Theoretical Findings
    Hendrickson, Rebecca C.
    Thomas, Ronald G.
    Schork, Nicholas J.
    Raskind, Murray A.
    FRONTIERS IN DIGITAL HEALTH, 2020, 2
12345